Research output per year
Research output per year
Fingerprint
Dive into the research topics where Daniela Maria Rossi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Post-Operative Patients’ Satisfaction and Quality of Life Assessment in Adult Patients with Obstructive Sleep Apnea Syndrome (OSAS)
Rossi, D. S., Goker, F., Cullati, F., Baj, A., Pignatelli, D., Gianni, A. B. & Del Fabbro, M., May 1 2022, In: International Journal of Environmental Research and Public Health. 19, 10, 6273.Research output: Contribution to journal › Article › peer-review
Open Access -
A Monolayer System for the Efficient Generation of Motor Neuron Progenitors and Functional Motor Neurons from Human Pluripotent Stem Cells
Cutarelli, A., Martínez-Rojas, V. A., Tata, A., Battistella, I., Rossi, D., Arosio, D., Musio, C. & Conti, L., May 7 2021, In: Cells. 10, 5, p. 1127Research output: Contribution to journal › Article › peer-review
-
Assessment of the 4-factor score: Retrospective analysis of 586 CLL patients receiving ibrutinib. A campus CLL study: American Journal of Hematology
Morabito, F., Tripepi, G., Del Poeta, G., Mauro, F. R., Reda, G., Sportoletti, P., Laurenti, L., Coscia, M., Herishanu, Y., Varettoni, M., Murru, R., Chiarenza, A., Visentin, A., Condoluci, A., Moia, R., Pietrasanta, D., Loseto, G., Consoli, U., Scortechini, I., Rossi, F. M., & 27 others, 2021, In: Am. J. Hematol.. 96, 5, p. E168-E171 4 p.Research output: Contribution to journal › Article › peer-review
-
Comparison of ibrutinib and idelalisib plus rituximab in real-life relapsed/resistant chronic lymphocytic leukemia cases
Morabito, F., Tripepi, G., Del Poeta, G., Mauro, F. R., Reda, G., Sportoletti, P., Laurenti, L., Coscia, M., Herishanu, Y., Bossio, S., Varettoni, M., Murru, R., Chiarenza, A., Visentin, A., Condoluci, A., Moia, R., Pietrasanta, D., Loseto, G., Consoli, U., Scortechini, I., & 30 others, 2021, In: European Journal of Haematology. 106, 4, p. 493-499 7 p.Research output: Contribution to journal › Article › peer-review
-
Comparison of ibrutinib and idelalisib plus rituximab in real-life relapsed/resistant chronic lymphocytic leukemia cases: European Journal of Haematology
Italian multicenter working group on CLL (Campus CLL), 2021, In: Eur. J. Haematol.. 106, 4, p. 493-499 7 p.Research output: Contribution to journal › Article › peer-review